AlphaNavi Pharma

About:

AlphaNavi Pharma is a medial company that specializes in the research and development of new drugs.

Top Investors: SMBC Venture Capital, Kyoto University Innovation Capital, Nippon Venture Capital, Chushin Venture Capital, Shinsei Capital Partners

Description:

AlphaNavi Pharma is a biotechnology company. They develop a novel analgesic drug for patients suffering from pain, their families, and medical professionals. They are engaged in research and clinical development and create new values by collaborating with academia and investors.

Total Funding Amount:

900M JPY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Osaka, Osaka, Japan

Founded Date:

2019-01-29

Contact Email:

info(AT)alphanavi.com

Founders:

Yoshihiro Oyamada

Number of Employees:

11-50

Last Funding Date:

2019-04-05

IPO Status:

Private

Industries: